Cancer treatment is moving towards more personalized medicine; Personalized cancer medicine comes from studies of human genes and the genes in different cancers. These studies have helped researchers design more effective treatments. They have also used genetic information to develop tests for cancer and ways to prevent it.

 Personalized cancer medicine can have fewer side effects than other types of treatment. This is because it is designed to be more specific. Personalized treatment may affect healthy cells less and cells involved in cancer more. 

 With new research on the human microbiome and its impact on human health, we believe microbiome modulation and tracking is going to be an integral part of personalized cancer care

Who we are

CareBiom is founded by a team of scientists, business experts, and clinicians with a focus on developing personalized cancer care and cancer wellness programs. By combining our founders and management team’s proven experience in microbiome science, cancer diagnostics, and translational research, we have created a powerful platform to develop transformative therapies to dramatically improve patients’ lives. We’re developing precision diagnostics, adjunct therapies, and long-term cancer wellness programs that make a real meaningful impact on the quality of life for patients.

Learn More

Our vision

We believe core microbiome that evolved with you into a ‘matured organ’ play a vital role in your health and wellness.

Read more

Our Mission

Collaborate with patients, researchers & clinicians to develop, and commercialize personalized treatment..

Read more

Why now?

We are at an exciting convergence of exceptional scientific strides in human genomics and microbiome..

Read more